HI homepage

Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.

As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals. 

technologist MRI rad tech radiologic radiology

Compared to other healthcare workers, technologists may have a more positive outlook of their career trajectories and how outside forces may affect them.

prostate cancer PSA

The drug has shown a “clinically meaningful benefit” in these patients, suggesting its potential as an earlier treatment option than previously thought, Novartis reports. 

Dean Kereiakes, a nationally renowned interventional cardiologist and president of The Christ Hospital Heart and Vascular Institute, has long been recognized for his groundbreaking work in cardiovascular research and intervention. But in 2024, his career and his life were permanently altered when decades of wearing heavy lead protection in the cath lab left him paralyzed.

Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.

Child Sniffs Flower

New findings published in Biological Psychiatry provide insight into the connection between time spent outside and improvements in neurodevelopment.

Calcified carotid plaques more likely to rupture than previously believed

Ruptured plaques can lead to the formation of blood clots that significantly increase the risk of stroke.

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.